| | The SEP domain of p47 acts as a reversible competitive inhibitor of cathepsin LEdited by Amy McGough Received 20 July 2004; received in revised form 13 September 2004; accepted 13 September 2004. published online 27 September 2004. Abstract The solution structure of the human p47 SEP domain in a construct comprising residues G1-S2-p47(171–270) was determined by NMR spectroscopy. A structure-derived hypothesis about the domains' function was formulated and pursued in binding experiments with cysteine proteases. The SEP domain was found to be a reversible competitive inhibitor of cathepsin L with a Ki of 1.5 μM. The binding of G1-S2-p47(171–270) to cathepsin L was mapped by biochemical assays and the binding interface was investigated by NMR chemical shift perturbation experiments. a Forschungsinstitut für Molekulare Pharmakologie, Robert-Rössle Str. 10, D-13125 Berlin, Germany b Proteinstrukturfabrik, Berlin, Germany c Max Planck Institut für Molekulare Genetik, Berlin, Germany d Freie Universitaet Berlin, Berlin, Germany e Department of Clinical Chemistry and Clinical Biochemistry, LMU Munich, Germany Corresponding author. Fax: +493094793169
PII: S0014-5793(04)01153-6 doi:10.1016/j.febslet.2004.09.037 © 2004 Federation of European Biochemical Societies | |
|
|